Skip to main content
Natco Pharma Ltd. logo

Natco Pharma Ltd. — Investor Relations & Filings

Ticker · NATCOPHARM ISIN · INE987B01026 LEI · 33580086GIBRWXSNGG39 BSE.NS Manufacturing
Filings indexed 1,707 across all filing types
Latest filing 2023-05-29 Regulatory Filings
Country IN India
Listing BSE.NS NATCOPHARM

About Natco Pharma Ltd.

https://www.natcopharma.co.in/

Natco Pharma Ltd. is a vertically integrated organization focused on the development, manufacturing, and marketing of complex generics and active pharmaceutical ingredients (APIs). The company specializes in niche therapeutic areas, maintaining a leadership position in oncology and a significant presence in specialty segments such as hepatology, cardiology, and diabetology. Natco is recognized for its expertise in high-barrier-to-entry products, including complex oral solids and injectables. Its business model emphasizes research and development to deliver affordable versions of life-saving medicines globally. With a robust portfolio of finished dosage formulations and a strong supply chain for APIs, the company serves diverse international markets, including North America, Europe, and emerging economies, through strategic partnerships and direct distribution channels.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for the year ended 31st March 2023
Regulatory Filings
2023-05-29 English
Related Party Transactions for the half year ended March 31, 2023.
Regulatory Filings
2023-05-29 English
Related Party Transactions
Regulatory Filings
2023-05-29 English
Outcome of Board Meeting
Regulatory Filings
2023-05-29 English
Audited Financial Results for the quarter and year ended 31st March, 2023
Regulatory Filings
2023-05-29 English
NATCO records INR 2811.7 Crore consolidated revenue and INR 715.3 Crore of Profit after tax for the year ended March 31st, 2023
Regulatory Filings
2023-05-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.